Koers Amarin Corporation plc (ADR) Xetra
Aandelen
EH3A
US0231112063
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- EUR | - |
Omzet 2024 * | 202 mln. 186 mln. | Omzet 2025 * | 215 mln. 198 mln. | Marktkapitalisatie | 357 mln. 329 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -70 mln. -64,41 mln. | Nettowinst (verlies) 2025 * | -64 mln. -58,89 mln. | EV/omzet 2024 * | 1,55 x |
Nettoliquiditeiten 2024 * | 43,92 mln. 40,41 mln. | Nettoliquiditeiten 2025 * | 159 mln. 146 mln. | EV/omzet 2025 * | 0,93 x |
K/w-verhouding 2024 * |
-4,93
x | K/w-verhouding 2025 * |
-5,23
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,48% |
Recentste transcriptie over Amarin Corporation plc (ADR)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Holt
CEO | Chief Executive Officer | 52 | 18-07-23 |
Thomas Reilly
DFI | Director of Finance/CFO | 52 | 20-06-22 |
Compliance Officer | 55 | 15/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Louis Sterling
BRD | Director/Board Member | 45 | 28-02-23 |
Odysseas Kostas
CHM | Chairman | 49 | 28-02-23 |
Keith Horn
BRD | Director/Board Member | 66 | 28-02-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,42% | 115 mld. | |
+11,84% | 106 mld. | |
-1,05% | 21,96 mld. | |
-14,15% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-4,16% | 18,08 mld. | |
-38,29% | 17,71 mld. | |
+7,99% | 14,32 mld. | |
+36,24% | 12,42 mld. |
- Beurs
- Aandelen
- Koers AMRN
- Koers EH3A